Capstone Holding Corp. revenue for the last year amounted to 44.88 M USD, the most of which — 48.35 M USD — came from its highest performing source at the moment, Novel Peptides and Other Molecules, the year earlier bringing 61.56 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Capstone Holding Corp. 48.35 M USD, and the year before that — 61.56 M USD.